Hsu Frank J. 4
4 · Oncternal Therapeutics, Inc. · Filed Aug 28, 2019
Insider Transaction Report
Form 4
Hsu Frank J.
Chief Medical Officer
Transactions
- Award
Stock Option
2019-08-26−150,000→ 150,000 totalExercise: $5.64Exp: 2029-08-26→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the shares subject to the stock options shall vest on first anniversary of the date of grant, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments over the three-year period thereafter, subject to the Reporting Person's continued employment or service with the Issuer on each such date.